Syngene International Limited — Results, 23-01-2025: Integrated Filing- Financial

Syngene International Limited has announced a board meeting to review its financial results for the quarter and nine months ended December 31, 2024. The company reported total income of ₹8,951 million and a profit of ₹1,231 million for the quarter. Key drivers include strong revenue growth from operations, which reached ₹9,437 million, marking a positive trend. The recent acquisition of a biologics manufacturing facility is expected to enhance production capacity, positioning Syngene well for future growth. This solid performance may generate a positive outlook among retail investors, although potential risks from market fluctuations should be monitored.